Compare DERM & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | GENC |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 213.6M |
| IPO Year | 2021 | 1995 |
| Metric | DERM | GENC |
|---|---|---|
| Price | $6.49 | $14.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $12.67 | ★ $17.60 |
| AVG Volume (30 Days) | ★ 144.4K | 26.1K |
| Earning Date | 05-13-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | 8.08 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $61,858,000.00 | $48,943,000.00 |
| Revenue This Year | $39.72 | N/A |
| Revenue Next Year | $63.24 | $25.51 |
| P/E Ratio | ★ N/A | $28.90 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $12.22 |
| 52 Week High | $9.56 | $16.82 |
| Indicator | DERM | GENC |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 41.35 |
| Support Level | $5.85 | $14.40 |
| Resistance Level | $6.59 | $14.59 |
| Average True Range (ATR) | 0.33 | 0.64 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 39.26 | 15.54 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.